flumazenil has been researched along with Adrenal Cancer in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turner, MC | 1 |
| DeQuattro, V | 1 |
| Falk, R | 1 |
| Ansari, A | 1 |
| Lieberman, E | 1 |
1 other study available for flumazenil and Adrenal Cancer
| Article | Year |
|---|---|
Childhood familial pheochromocytoma. Conflicting results of localization techniques.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Catecholamines; Child; Female; Humans; I | 1986 |